Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 785, pseudogene (RN7SL785P)** is a *processed pseudogene*—a nonfunctional genomic DNA sequence resembling the functional 7SL RNA gene but lacking the ability to produce a functional RNA or protein product[1][6][8][9]. The 7SL RNA itself is a critical non-coding RNA component of the signal recognition particle, involved in protein targeting to membranes, but RN7SL785P represents a truncated and nonfunctional copy that arose through reverse transcription and integration into the genome[1][3][8][9]. Such pseudogenes do not generally serve as drug targets or have established direct roles in disease; their primary relevance is evolutionary and genomic, and they are not suitable for therapeutic intervention or biomarker development[6][8][9]. While some pseudogenes in other contexts can act as regulatory non-coding RNAs (for example, as miRNA sponges), no such function is known for RN7SL785P specifically[4].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 785, pseudogene (RN7SL785P).